MIRA INFORM REPORT
|
Report Date : |
25.02.2012 |
IDENTIFICATION DETAILS
|
Correct Name : |
SHENZHEN YUANBANG BIOTECHNOLOGY CO., LTD. |
|
|
|
|
Registered Office : |
Room 506, University City Pioneer Park, Lishan
Road, Taoyuan Street, Nanshan District, Shenzhen, Guangdong Province 518052
Pr |
|
|
|
|
Country : |
China |
|
|
|
|
Date of Incorporation : |
20.07.2010 |
|
|
|
|
Com. Reg. No.: |
440301104821111 |
|
|
|
|
Legal Form : |
Limited Liabilities Company |
|
|
|
|
Line of Business : |
Selling
Biological
Products and Chemical Raw Materials |
|
|
|
|
No. of Employees : |
4
Persons |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment
Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30th, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
China |
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
shenzhen yuanbang biotechnology co., ltd.
(trade name: Health
Creation Industrial Ltd.)
room 506, University
City Pioneer Park, lishan road
taoyuan street,
nanshan district, shenzhen
guangdong province
518052 PR CHINA
TEL: 86 (0)
755-33229873
FAX: N/A
Date of Registration : JULY 20, 2010
REGISTRATION NO. : 440301104821111
LEGAL FORM : Limited liabilities company
REGISTERED CAPITAL : CNY 2,000,000
staff : 4
BUSINESS CATEGORY :
TRADING
Revenue : N/A
EQUITIES : N/A
WEBSITE : N/A
E-MAIL :
N/A
PAYMENT : AVERAGE
Recommended Credit Limit: C.O.D. to
small amount
MARKET CONDITION : fair
FINANCIAL CONDITION : n/a
OPERATIONAL TREND : Ordinary
GENERAL REPUTATION : AVERAGE
EXCHANGE RATE : CNY 6.39 = USD 1
(as follows)
SC - Subject Company
(the company inquired by you)
N/A – Not available
CNY – China Yuan Ren
Min Bi
This section aims at indicating the relative positions of SC in respect
of its operational trend & general reputation
Operational Trend:- General
Reputation:-
Upward Excellent
Steady Good
Fairly Steady Fairly
Good
Ordinary Average
Fair Fair
Stagnant Detrimental
Downward Not
known
Not known Not
yet be determined
Not yet be determined
***Note: SC’s name should be the above stated one,
Health Creation Industrial Ltd. (the given name) is SC’s related company
registered in Hong Kong, and however, SC always uses this name as its trade
name. But SC’s employee refused to release the details about the given address
(Unit A5/F Max Share Ctr 373 King's Rd North Point Hong Kong).
SC was
established as a limited liabilities company of PRC with State Administration
of Industry & Commerce (SAIC) under registration No.: 440301104821111 on July 20,
2010.
SC’s Organization Code Certificate
No.: 558687075

SC’s registered capital: CNY 2,000,000
SC’s paid-in capital: CNY 2,000,000
No significant changes of SC have
been noted in SAIC since its incorporation.
Current Co search indicates SC’s shareholders & chief
executives are as follows:-
|
Name of Shareholder (s) |
% of Shareholding |
|
Xiong Lidan |
5 |
|
Mei Feng |
95 |
SC’s Chief Executives:-
|
Position |
Name |
|
Legal Representative,
Chairman, and General Manager |
Mei
Feng |
|
Supervisor |
Tao Gengping |
No recent development was found during our checks at present.
Xiong Lidan 5
Mei Feng 95
Mei
Feng, Legal Representative, Chairman and General
Manager
---------------------------------------------------------------------------------------------
Ø
Gender: M
Ø
Qualification:
University
Ø
Working
experience (s):
From 2010 to present, working in SC as legal representative,
chairman and general manager
Tao Gengping, Supervisor
----------------------------------------------
Ø
Gender: M
Ø
Qualification:
University
SC’s registered business scope includes research and
technology development of biological products, chemical raw materials, economic
information consultation, wholesale of pharmaceutical raw materials, chemical
raw materials; business of international trade.
SC started its
normal operation in 2011.
SC is
mainly engaged in selling biological products and chemical raw materials.
SC’s products
mainly include: biological products, chemical raw materials
SC sources its materials 100% from domestic
market. SC sells 100% of its products to overseas market, mainly Southeast
Asian countries.
The buying
terms of SC include T/T and Credit of 30-60 days. The payment terms of SC
include L/C and Credit of 30-60 days.
Staff & Office:
--------------------------
SC is
known to have approx. 4 staff at present.
SC rents an area
as its operating office, but the detailed information is unknown.
u Health Creation Industrial Ltd.
(Hong Kong)
------------------------------------------------------
Date of Registration :
March 16, 2009
Registration No. :
1317401
Legal Form : Private
Status : Live
Overall payment appraisal:
( ) Excellent ( ) Good (X) Average ( ) Fair ( ) Poor ( ) Not yet be determined
The appraisal serves as a reference to reveal SC's payments habits and
ability to pay. It is based on the 3
weighed factors: Trade payment experience (through current enquiry with SC's
suppliers), our delinquent payment and our debt collection record concerning
SC.
Trade payment experience: SC did not
provide any name of trade/service suppliers and we have no other sources to
conduct the enquiry at present.
Delinquent payment record: None in our
database.
Debt collection record: No overdue amount
owed by SC was placed to us for collection within the last 6 years.
The bank information
of SC is not filed in SAIC.
Established in 2010, SC started its normal operation in 2011, so its
financials are not available at present.
SC is considered small-sized in its line with a short business history.
Credit dealings with SC should be confined into C.O.D. to small amount at
present.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.49.06 |
|
UK Pound |
1 |
Rs.77.19 |
|
Euro |
1 |
Rs.65.57 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.